Jonathan Hill, James Spratt, Charalambos Antoniades, et al

Watch time: 11h 6m 44s (20 videos)

About

Transcatheter therapy of structural heart disease is advancing rapidly. Due to the less invasive approach, transcatheter techniques have replaced surgery as the standard procedure for atrial septal defect and patent foramen ovale closure.

Evolving interventional techniques allow treatment of paravalvular leaks, ventricular septal defects and valve replacement, especially the rapid evolution and newer indications for transcatheter aortic valve replacement (TAVR).

Articles

APSC Consensus Recommendations for MitraClip in MR

Published:

01 June 2021

Citation:

European Cardiology Review 2021;16:e25.

The ISCHEMIA Trial: What is the Message for the Interventionalist?

Published:

01 June 2021

Citation:

European Cardiology Review 2021;16:e24.

Comments on TARGET FFR and DEFINE-FLOW Trials Presented at TCT Connect 2020

Published:

27 April 2021

Citation:

European Cardiology Review 2021;16:e17.

Editorial: The EXCEL Trial

Published:

30 March 2021

Citation:

European Cardiology Review 2021;16:e09.